Sarepta Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 05/02/2025 | 9.91 M | $632.26 M | -11.48% | 10.18% |
CAPITAL INTERNATIONAL INVESTORS | 05/12/2025 | 9.06 M | $578.29 M | 4.18% | 9.31% |
VANGUARD GROUP INC | 05/09/2025 | 9.03 M | $576.46 M | -0.58% | 9.28% |
STATE STREET CORP | 05/15/2025 | 4.07 M | $259.65 M | -0.03% | 4.18% |
JANUS HENDERSON GROUP PLC | 05/15/2025 | 3.36 M | $236.88 M | -22.26% | 3.46% |
AVORO CAPITAL ADVISORS LLC | 05/15/2025 | 2.67 M | $170.71 M | 4.67% | 2.75% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 2.65 M | $168.91 M | 27.93% | 2.72% |
FARALLON CAPITAL MANAGEMENT LLC | 05/15/2025 | 2.34 M | $149.43 M | -18.28% | 2.40% |
JPMORGAN CHASE & CO | 05/12/2025 | 2.24 M | $143.24 M | 11.08% | 2.31% |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/14/2025 | 2.00 M | $127.51 M | 2.12% | 2.05% |
MORGAN STANLEY | 05/15/2025 | 1.97 M | $125.86 M | 98.87% | 2.03% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.82 M | $116.24 M | 6.71% | 1.87% |
DEUTSCHE BANK AG\ | 05/09/2025 | 1.66 M | $106.17 M | 0.01% | 1.71% |
UBS GROUP AG | 05/13/2025 | 1.45 M | $92.31 M | -2.27% | 1.49% |
GROUPAMA ASSET MANAGMENT | 05/14/2025 | 1.30 M | $1.23 M | 0.00% | 1.34% |
ECOR1 CAPITAL, LLC | 05/15/2025 | 1.29 M | $82.48 M | 67.84% | 1.33% |
05/14/2025 | 1.06 M | $62.76 M | 49.82% | 1.09% | |
PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 937.02 K | $60.73 M | -10.42% | 0.96% |
CASDIN CAPITAL, LLC | 05/15/2025 | 900.78 K | $57.49 M | -16.09% | 0.93% |
DEEP TRACK CAPITAL, LP | 05/15/2025 | 899.73 K | $57.42 M | 100.00% | 0.92% |
ALKEON CAPITAL MANAGEMENT LLC | 05/15/2025 | 853.85 K | $54.49 M | 0.00% | 0.88% |
CAMBER CAPITAL MANAGEMENT LP | 05/15/2025 | 800.00 K | $51.06 M | -20.00% | 0.82% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 791.08 K | $50.49 M | -63.13% | 0.81% |
NORTHERN TRUST CORP | 05/13/2025 | 769.82 K | $49.13 M | -4.19% | 0.79% |
ASSENAGON ASSET MANAGEMENT S.A. | 04/15/2025 | 712.58 K | $45.48 M | 437.97% | 0.73% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 692.15 K | $44.17 M | 13.54% | 0.71% |
ABRDN PLC | 05/13/2025 | 650.28 K | $41.68 M | 42.08% | 0.67% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 646.29 K | $41.25 M | 3.61% | 0.66% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 586.32 K | $37.44 M | 88.64% | 0.60% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 550.88 K | $35.16 M | 633.98% | 0.57% |
ROYAL BANK OF CANADA | 05/15/2025 | 543.38 K | $34.68 M | -5.12% | 0.56% |
UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 463.34 K | $29.57 M | 54.81% | 0.48% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 457.33 K | $29.19 M | 100.00% | 0.47% |
AMUNDI | 05/15/2025 | 456.79 K | $26.77 M | 0.67% | 0.47% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 456.60 K | $29.14 M | -2.42% | 0.47% |
BARCLAYS PLC | 05/15/2025 | 445.66 K | $28.44 M | -9.06% | 0.46% |
FMR LLC | 05/12/2025 | 422.49 K | $26.96 M | -39.02% | 0.43% |
FIRST TRUST ADVISORS LP | 05/14/2025 | 394.17 K | $25.16 M | 26.42% | 0.40% |
CITIGROUP INC | 05/12/2025 | 383.83 K | $24.50 M | 418.02% | 0.39% |
RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 362.90 K | $23.16 M | -8.55% | 0.37% |
05/12/2025 | 352.74 K | $22.51 M | 100.00% | 0.36% | |
FIERA CAPITAL CORP | 05/07/2025 | 345.75 K | $22.07 M | -1.31% | 0.36% |
AMERIPRISE FINANCIAL INC | 05/14/2025 | 336.79 K | $21.49 M | 8.29% | 0.35% |
THRIVENT FINANCIAL FOR LUTHERANS | 05/13/2025 | 332.92 K | $35.54 M | -47.93% | 0.34% |
SOFINNOVA INVESTMENTS, INC. | 05/15/2025 | 327.62 K | $20.91 M | -23.59% | 0.34% |
FEDERATED HERMES, INC. | 05/08/2025 | 292.13 K | $18.64 M | -23.21% | 0.30% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 276.33 K | $17.64 M | 100.00% | 0.28% |
RHUMBLINE ADVISERS | 05/29/2025 | 265.24 K | $16.93 M | -1.00% | 0.27% |
TWINBEECH CAPITAL LP | 05/15/2025 | 265.00 K | $16.91 M | 100.00% | 0.27% |
SQUAREPOINT OPS LLC | 05/15/2025 | 252.46 K | $16.11 M | 732.64% | 0.26% |
Sarepta Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 645 institutional investors and hedge funds held shares of Sarepta Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 9.91 M
Capital International Investors: 9.06 M
VANGUARD GROUP INC: 9.03 M
STATE STREET CORP: 4.07 M
JANUS HENDERSON GROUP PLC: 3.36 M
Avoro Capital Advisors LLC: 2.67 M
89.65% of Sarepta Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 109.63 M shares in the last 24 months. This purchase volume represents approximately $2.00 B in transactions.